QuidelOrtho Corporation, founded through the merger of Quidel Corporation and Ortho Clinical Diagnostics, focuses on enhancing healthcare through innovative diagnostic solutions. The company's core mission is to improve patient outcomes by providing advanced diagnostic technologies. QuidelOrtho offers a wide range of products and services, including clinical chemistry, immunoassay, molecular diagnostics, immunohematology, donor screening, and point-of-care diagnostics. Their market focus spans across hospitals, laboratories, and clinics globally.
Notable figures associated with QuidelOrtho include key executives from both legacy companies who have extensive experience in the diagnostics industry. The company has received significant investment from leading healthcare investors. Key achievements include the development of cutting-edge diagnostic platforms that have significantly improved disease detection and management. QuidelOrtho's impact is evident in its contribution to more accurate and timely diagnostics, thereby enhancing patient care worldwide.
